IGM Biosciences, Inc. (IGMS)

Au 14, 2025 - IGMS was delisted (reason: acquired by Concentra Biosciences)

1.270

-0.030 (-2.31%)

Inactive · Last trade price on Aug 13, 2025

IGM Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2020
Period Ending	Aug '25 Aug 13, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2020
Market Capitalization	-	363	485	728	952	2,818	Upgrade
Market Cap Growth	-83.40%	-25.13%	-33.39%	-23.49%	-66.22%	141.87%	Upgrade
Enterprise Value	-	190	139	287	722	2,651	Upgrade
Last Close Price	-	6.11	8.31	17.01	29.33	88.29	Upgrade
PS Ratio	-	135.62	227.82	681.46	-	-	Upgrade
PB Ratio	-	7.54	2.39	2.54	3.89	7.38	Upgrade
P/TBV Ratio	-	7.54	2.39	2.54	3.89	7.38	Upgrade
EV/Sales Ratio	-	71.07	65.47	268.87	-	-	Upgrade
Debt / Equity Ratio	-	0.94	0.20	0.14	0.12	0.03	Upgrade
Asset Turnover	0.65	0.01	0.01	0.00	-	-	Upgrade
Quick Ratio	17.30	4.90	7.97	9.57	8.26	21.25	Upgrade
Current Ratio	17.66	5.14	8.18	9.81	8.67	21.65	Upgrade
Return on Equity (ROE)	-47.82%	-155.76%	-100.48%	-83.09%	-52.71%	-26.16%	Upgrade
Return on Assets (ROA)	2.89%	-35.23%	-34.91%	-35.11%	-29.24%	-15.54%	Upgrade
Return on Capital (ROIC)	4.88%	-72.02%	-57.16%	-47.33%	-30.95%	-16.04%	Upgrade
Earnings Yield	-	-53.89%	-50.78%	-30.35%	-17.35%	-2.89%	Upgrade
FCF Yield	-	-43.72%	-42.17%	-2.20%	-14.52%	-3.03%	Upgrade
Buyback Yield / Dilution	-1.64%	-15.68%	-25.92%	-24.09%	-8.88%	-241.82%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q